98 related articles for article (PubMed ID: 9669475)
1. Controlled therapeutic trials of pentoxifylline in relapsing-experimental auto-immune encephalomyelitis.
Grassin M; Brochet B; Coussemacq M; Brochet H
Acta Neurol Scand; 1998 Jun; 97(6):404-8. PubMed ID: 9669475
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline inhibits experimental allergic encephalomyelitis.
Nataf S; Louboutin JP; Chabannes D; Fève JR; Muller JY
Acta Neurol Scand; 1993 Aug; 88(2):97-9. PubMed ID: 8213066
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells.
Okuda Y; Sakoda S; Fujimura H; Yanagihara T
Immunopharmacology; 1996 Nov; 35(2):141-8. PubMed ID: 8956977
[TBL] [Abstract][Full Text] [Related]
4. Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).
Corrêa JO; Aarestrup BJ; Aarestrup FM
Exp Neurol; 2010 Nov; 226(1):15-23. PubMed ID: 20406639
[TBL] [Abstract][Full Text] [Related]
5. Prevention studies with pentoxifylline: new clinical projects.
Eugène-Jolchine I; Milpied N
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S143-6. PubMed ID: 8699855
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.
Liedtke W; Cannella B; Mazzaccaro RJ; Clements JM; Miller KM; Wucherpfennig KW; Gearing AJ; Raine CS
Ann Neurol; 1998 Jul; 44(1):35-46. PubMed ID: 9667591
[TBL] [Abstract][Full Text] [Related]
7. Effect of muscular exercise on chronic relapsing experimental autoimmune encephalomyelitis.
Le Page C; Ferry A; Rieu M
J Appl Physiol (1985); 1994 Nov; 77(5):2341-7. PubMed ID: 7868453
[TBL] [Abstract][Full Text] [Related]
8. Functional protection of pentoxifylline against spinal cord ischemia/reperfusion injury in rabbits: necrosis and apoptosis effects.
Zhu DJ; Xia B; Bi Q; Zhang SJ; Qiu BS; Zhao C
Chin Med J (Engl); 2008 Dec; 121(23):2444-9. PubMed ID: 19102966
[TBL] [Abstract][Full Text] [Related]
9. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
[TBL] [Abstract][Full Text] [Related]
10. N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Bolton C; Wood EG; Ayoub SS
Fundam Clin Pharmacol; 2013 Oct; 27(5):535-43. PubMed ID: 22742874
[TBL] [Abstract][Full Text] [Related]
11. Topical pentoxifylline for pressure ulcer treatment: a randomised, double-blind, placebo-controlled clinical trial.
Najafi E; Ahmadi M; Mohammadi M; Beigmohammadi MT; Heidary Z; Vatanara A; Khalili H
J Wound Care; 2018 Aug; 27(8):495-502. PubMed ID: 30086256
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
Schorlemmer HU; Seiler FR
Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis.
Penkowa M; Hidalgo J
Glia; 2000 Dec; 32(3):247-63. PubMed ID: 11102966
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.
Volman TJ; Goris RJ; Hendriks T
Intensive Care Med; 2005 May; 31(5):701-8. PubMed ID: 15711975
[TBL] [Abstract][Full Text] [Related]
15. Improvement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trial.
Noel C; Hazzan M; Labalette M; Coppin MC; Jude B; Dessaint JP; Lelievre G
Transplantation; 1998 Feb; 65(3):385-9. PubMed ID: 9484756
[TBL] [Abstract][Full Text] [Related]
16. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study.
Zeni F; Pain P; Vindimian M; Gay JP; Gery P; Bertrand M; Page Y; Page D; Vermesch R; Bertrand JC
Crit Care Med; 1996 Feb; 24(2):207-14. PubMed ID: 8605790
[TBL] [Abstract][Full Text] [Related]
17. A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction.
Muller DM; Pender MP; Greer JM
Acta Neuropathol; 2000 Aug; 100(2):174-82. PubMed ID: 10963365
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis.
Windmeier C; Gressner AM
Gen Pharmacol; 1997 Aug; 29(2):181-96. PubMed ID: 9251897
[TBL] [Abstract][Full Text] [Related]
20. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ.
Ohmori K; Hong Y; Fujiwara M; Matsumoto Y
Lab Invest; 1992 Jan; 66(1):54-62. PubMed ID: 1731149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
